Qilin Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Juvenile Idiopathic Arthritis

Top Venues

Pharmaceuticals (Basel, Switzerland)

Disease markers

CNS neuroscience & therapeutics

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Wenting Zhang, Ziqi Xu, Yamin Shu, Sainan Shu, Qilin Zhang
Adverse Event Profiles of Adalimumab in Children: A Disproportionality Analysis. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Wenting Zhang, Ziqi Xu, Yamin Shu, Sainan Shu, Qilin Zhang
Adverse Event Profiles of Adalimumab in Children: A Disproportionality Analysis. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Yamin Shu, Lei Wang, Yiling Ding, Qilin Zhang
Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment. Drug safety (2023)
Yamin Shu, Yiling Ding, Lulu Liu, Qilin Zhang
Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system. CNS neuroscience & therapeutics (2023)
Yamin Shu, Yufeng Ding, Xucheng He, Yanxin Liu, Pan Wu, Qilin Zhang
Hematological toxicities in PARP inhibitors: A real-world study using FDA adverse event reporting system (FAERS) database. Cancer medicine (2022)
Qilin Zhang, Ziming Zheng, Yu Zhang
Association of Myocardial Enzyme Abnormality with Clinical Outcomes of Patients with COVID-19: A Retrospective Study. Disease markers 2021 (2021)